positionForPages[76]={page:76,positions:[{w:"68",p:[0.092505,0.957873,0.109687,0.957873,0.109687,0.938882,0.092505,0.938882,0.008591,0.008591]},{w:"3",p:[0.038824,0.310836,0.060302,0.310836,0.060302,0.263358,0.038824,0.263358,0.021478]},{w:"CHAPTER 3",p:[0.117647,0.067219,0.190423,0.067219,0.190423,0.047140,0.117647,0.047140,0.009172,0.009650,0.008799,0.008861,0.007388,0.007906,0.009359,0.003320,0.008321]},{w:"piridol, were present in our cohort",p:[0.117647,0.121273,0.406066,0.121273,0.406066,0.100900,0.117647,0.100900,0.011071,0.005615,0.007807,0.005547,0.011322,0.010934,0.004976,0.004497,0.004086,0.014520,0.009039,0.007442,0.009039,0.004086,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006437,0.004086,0.005615,0.011756,0.004086,0.010820,0.011413,0.007807,0.004086,0.008994,0.010934,0.011299,0.010843,0.007967,0.006437]},{w:"291–293",p:[0.406023,0.113657,0.449394,0.113657,0.449394,0.101780,0.406023,0.101780,0.006082,0.006082,0.006082,0.006880,0.006082,0.006082,0.006082]},{w:". ",p:[0.449392,0.121273,0.457998,0.121273,0.457998,0.100900,0.449392,0.100900,0.004497,0.004109]},{w:"CDKN2A ",p:[0.457967,0.121742,0.550621,0.121742,0.550621,0.099720,0.457967,0.099720,0.014495,0.015887,0.014906,0.016093,0.010888,0.015157,0.005227]},{w:"was affected in the two PDOs which ",p:[0.550581,0.121273,0.857099,0.121273,0.857099,0.100900,0.550581,0.100900,0.014723,0.009291,0.007670,0.004086,0.009087,0.005969,0.005787,0.009106,0.009108,0.006209,0.009108,0.011391,0.004086,0.005615,0.011756,0.004086,0.006620,0.011299,0.009039,0.004086,0.006437,0.014518,0.011048,0.004086,0.011664,0.016504,0.016253,0.007670,0.004086,0.014792,0.011459,0.005547,0.008765,0.011459,0.004109]},{w:"were the least responsive to flavopiridol: MBT-2.1 showed loss of both alleles and END-",p:[0.117647,0.141852,0.852923,0.141852,0.852923,0.121479,0.117647,0.121479,0.014518,0.009039,0.007442,0.009039,0.004291,0.006620,0.011299,0.009039,0.004291,0.005182,0.009288,0.009291,0.007512,0.006437,0.004291,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.004291,0.006211,0.011048,0.004291,0.005638,0.005821,0.008925,0.009633,0.010820,0.011071,0.005615,0.007807,0.005547,0.011322,0.010934,0.005250,0.004497,0.004291,0.019608,0.012395,0.011801,0.007533,0.010432,0.004497,0.010432,0.004291,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.004291,0.005182,0.010957,0.007533,0.007670,0.004291,0.010843,0.006209,0.004291,0.011251,0.010820,0.006620,0.011459,0.004291,0.009405,0.005387,0.005182,0.008948,0.005182,0.009039,0.007670,0.004291,0.009085,0.011596,0.011391,0.004291,0.012098,0.016230,0.016139,0.007533]},{w:"1.1 harbored a nonsense variant (p.(R58*); ",p:[0.117647,0.162431,0.479132,0.162431,0.479132,0.142058,0.117647,0.142058,0.010432,0.004497,0.010432,0.004565,0.011391,0.009085,0.007715,0.011254,0.010843,0.007442,0.009108,0.011391,0.004565,0.009291,0.004565,0.011596,0.010843,0.011621,0.007873,0.009039,0.011619,0.007875,0.009039,0.004565,0.009838,0.009085,0.007807,0.005798,0.009085,0.011391,0.006437,0.004565,0.006939,0.010500,0.004497,0.006939,0.013376,0.010432,0.010432,0.008172,0.006939,0.004497,0.004109]},{w:"Figure 2I",p:[0.479570,0.162431,0.561094,0.162431,0.561094,0.141298,0.479570,0.141298,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.004460,0.010911,0.007967]},{w:"), while copy number loss of ",p:[0.561094,0.162431,0.803010,0.162431,0.803010,0.142058,0.561094,0.142058,0.006939,0.004497,0.004565,0.014792,0.011459,0.005750,0.005182,0.009039,0.004565,0.008994,0.010820,0.011094,0.009724,0.004565,0.011391,0.011413,0.017394,0.011254,0.009039,0.007807,0.004565,0.005182,0.010957,0.007533,0.007670,0.004565,0.010843,0.006209,0.004109]},{w:"XIAP",p:[0.803453,0.162900,0.852942,0.162900,0.852942,0.140877,0.803453,0.140877,0.014655,0.007031,0.015157,0.012646]},{w:" ",p:[0.852941,0.162431,0.857050,0.162431,0.857050,0.142058,0.852941,0.142058,0.004109]},{w:"was observed in two of the flavopiridol high-responsive PDOs (",p:[0.117647,0.183009,0.671375,0.183009,0.671375,0.162636,0.117647,0.162636,0.014723,0.009291,0.007670,0.006460,0.010957,0.010934,0.007873,0.009039,0.008400,0.009633,0.009108,0.011391,0.006460,0.005615,0.011756,0.006460,0.006437,0.014518,0.011048,0.006460,0.010843,0.006209,0.006460,0.006620,0.011299,0.009039,0.006460,0.005638,0.005819,0.008925,0.009635,0.010820,0.011071,0.005615,0.007807,0.005545,0.011322,0.010934,0.005250,0.006460,0.011459,0.005615,0.009930,0.011459,0.007533,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.006460,0.011664,0.016504,0.016253,0.007670,0.006460,0.006939]},{w:"Figure 2I",p:[0.671332,0.183009,0.754706,0.183009,0.754706,0.161876,0.671332,0.161876,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.006312,0.010911,0.007967]},{w:"). All ",p:[0.754706,0.183009,0.802414,0.183009,0.802414,0.162636,0.754706,0.162636,0.006939,0.004497,0.006460,0.015066,0.005387,0.005250,0.004109]},{w:"TP53 ",p:[0.804754,0.183478,0.858169,0.183478,0.858169,0.161456,0.804754,0.161456,0.013765,0.012646,0.010888,0.010888,0.005227]},{w:"wildtype PDOs (N=7) were classified into the low-responsive subgroup of WEE1-inhib-",p:[0.117647,0.203588,0.852941,0.203588,0.852941,0.183215,0.117647,0.183215,0.014723,0.005752,0.005182,0.011048,0.006437,0.009724,0.011502,0.009039,0.003858,0.011664,0.016501,0.016253,0.007670,0.003858,0.006939,0.016230,0.011779,0.010432,0.006939,0.003846,0.014518,0.009039,0.007442,0.009039,0.003858,0.008768,0.005430,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.011391,0.003858,0.005615,0.011391,0.006209,0.011048,0.003858,0.006620,0.011299,0.009039,0.003858,0.005184,0.010866,0.014723,0.007533,0.007439,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.003858,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.003858,0.010843,0.006209,0.003858,0.021001,0.012098,0.012098,0.010432,0.007533,0.005615,0.011870,0.011459,0.005547,0.010945,0.007533]},{w:"itor adavosertib, while ",p:[0.117647,0.224167,0.307997,0.224167,0.307997,0.203794,0.117647,0.203794,0.005273,0.006209,0.010843,0.007807,0.003949,0.009291,0.011573,0.008925,0.009633,0.010957,0.007875,0.009039,0.007967,0.006437,0.005547,0.010249,0.004497,0.003949,0.014789,0.011459,0.005752,0.005182,0.009039,0.004109]},{w:"TP53",p:[0.307838,0.224636,0.356025,0.224636,0.356025,0.202613,0.307838,0.202613,0.013765,0.012646,0.010888,0.010888]},{w:" mutants (N=15) were distributed among both the low- and ",p:[0.356025,0.224167,0.857050,0.224167,0.857050,0.203794,0.356025,0.203794,0.003949,0.017280,0.011071,0.006551,0.009085,0.011391,0.006437,0.007670,0.003949,0.006939,0.016230,0.011779,0.010432,0.010432,0.006939,0.003949,0.014518,0.009039,0.007442,0.009039,0.003949,0.011391,0.005615,0.007510,0.006437,0.007807,0.005547,0.010797,0.011071,0.006209,0.009108,0.011391,0.003949,0.009085,0.017485,0.010843,0.011459,0.009861,0.003949,0.011254,0.010820,0.006620,0.011459,0.003949,0.006620,0.011299,0.009039,0.003949,0.005182,0.010866,0.014723,0.007533,0.003949,0.009085,0.011596,0.011391,0.004109]},{w:"high-responsive PDOs (",p:[0.117647,0.244745,0.321056,0.244745,0.321056,0.224373,0.117647,0.224373,0.011459,0.005615,0.009930,0.011459,0.007533,0.007442,0.009039,0.007510,0.011502,0.010845,0.011619,0.007601,0.005547,0.009633,0.009039,0.004303,0.011664,0.016504,0.016253,0.007670,0.004303,0.006939]},{w:"Figure 2J",p:[0.321057,0.244745,0.401978,0.244745,0.401978,0.223613,0.321057,0.223613,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.004200,0.010911,0.007624]},{w:"). For the remaining drugs, alpelisib, AZD-8055, MK-",p:[0.401985,0.244745,0.852951,0.244745,0.852951,0.224373,0.401985,0.224373,0.006939,0.004497,0.004303,0.010683,0.010843,0.007807,0.004314,0.006617,0.011302,0.009039,0.004303,0.007442,0.009039,0.017577,0.009085,0.005615,0.011756,0.005615,0.011459,0.009861,0.004303,0.011391,0.007967,0.011413,0.009724,0.007670,0.004497,0.004303,0.009405,0.004908,0.011505,0.008948,0.005250,0.005615,0.007601,0.005547,0.010249,0.004497,0.004303,0.014929,0.012966,0.016139,0.007533,0.010432,0.010432,0.010432,0.010432,0.004497,0.004303,0.019608,0.014541,0.007533]},{w:"2206, and pictilisib, no known genotype and drug response phenotype correlations were ",p:[0.117647,0.265324,0.857144,0.265324,0.857144,0.244951,0.117647,0.244951,0.010432,0.010432,0.010432,0.010432,0.004497,0.003789,0.009085,0.011596,0.011391,0.003789,0.011073,0.005547,0.009106,0.006437,0.005752,0.005250,0.005615,0.007601,0.005547,0.010249,0.004497,0.003789,0.011596,0.011048,0.003789,0.010706,0.011596,0.010866,0.014723,0.011756,0.003789,0.009656,0.009039,0.011598,0.010820,0.006437,0.009724,0.011502,0.009039,0.003789,0.009085,0.011596,0.011391,0.003789,0.011391,0.007967,0.011413,0.009861,0.003789,0.007444,0.009039,0.007510,0.011502,0.010845,0.011619,0.007873,0.009039,0.003789,0.011162,0.011299,0.009039,0.011596,0.010820,0.006437,0.009724,0.011505,0.009039,0.003789,0.008994,0.010843,0.007807,0.007442,0.008948,0.005433,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.003789,0.014518,0.009039,0.007442,0.009039,0.004109]},{w:"observed.",p:[0.117647,0.285903,0.199205,0.285903,0.199205,0.265530,0.117647,0.265530,0.010957,0.010934,0.007875,0.009039,0.008398,0.009633,0.009108,0.011117,0.004497]},{w:"Subsequently, we evaluated for each individual patient how many of the tested mono-",p:[0.117647,0.306482,0.852941,0.306482,0.852941,0.286109,0.117647,0.286109,0.009793,0.011345,0.010934,0.007875,0.009108,0.010706,0.011345,0.009039,0.011391,0.006620,0.005182,0.007989,0.004497,0.005775,0.014518,0.009039,0.005775,0.009336,0.009838,0.009405,0.004908,0.011596,0.008811,0.006209,0.009108,0.011391,0.005775,0.006026,0.010843,0.007807,0.005775,0.009291,0.009291,0.008765,0.011459,0.005775,0.005615,0.011596,0.011391,0.005547,0.009838,0.005545,0.011048,0.011596,0.009405,0.005250,0.005775,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.005775,0.011302,0.010863,0.014723,0.005775,0.017577,0.009085,0.011368,0.009724,0.005775,0.010843,0.006209,0.005775,0.006620,0.011299,0.009039,0.005775,0.006209,0.009039,0.007510,0.006211,0.009106,0.011391,0.005775,0.017485,0.010843,0.011596,0.011094,0.007533]},{w:"therapies (3-13 per patient) remained as potential treatments based on an IC50-value ",p:[0.117647,0.327060,0.857139,0.327060,0.857139,0.306687,0.117647,0.306687,0.006620,0.011299,0.009039,0.007898,0.008811,0.011071,0.005547,0.009039,0.007670,0.006140,0.006939,0.010432,0.007533,0.010432,0.010432,0.006140,0.011505,0.009039,0.007807,0.006140,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.006939,0.006140,0.007442,0.009039,0.017577,0.009085,0.005615,0.011596,0.009108,0.011391,0.006140,0.009291,0.007670,0.006140,0.011505,0.010820,0.006209,0.009039,0.011391,0.006437,0.005798,0.009405,0.005250,0.006140,0.006437,0.007442,0.009288,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.007670,0.006140,0.011117,0.009291,0.007873,0.009108,0.011391,0.006140,0.010843,0.011756,0.006140,0.009087,0.011756,0.006140,0.006825,0.014678,0.010432,0.010432,0.007533,0.009838,0.009402,0.004908,0.011345,0.009039,0.004109]},{w:"smaller than the achievable concentration in patient plasma (C /C",p:[0.117647,0.347639,0.675335,0.347639,0.675335,0.327266,0.117647,0.327266,0.007601,0.017577,0.009405,0.005387,0.005182,0.009039,0.007807,0.003447,0.006620,0.011391,0.009085,0.011756,0.003447,0.006620,0.011299,0.009039,0.003447,0.009291,0.008765,0.011459,0.005547,0.009336,0.009838,0.009108,0.010911,0.005182,0.009039,0.003447,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.003447,0.005615,0.011756,0.003447,0.011365,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.003447,0.011162,0.005433,0.009291,0.007601,0.017577,0.009291,0.003447,0.006939,0.014678,0.015098,0.007099,0.014678]},{w:"ss max",p:[0.638402,0.348108,0.715122,0.348108,0.715122,0.326086,0.638402,0.326086,0.007464,0.007693,0.021776,0.017805,0.011185,0.010797]},{w:"). In case of mul-",p:[0.715121,0.347639,0.852941,0.347639,0.852941,0.327266,0.715121,0.327266,0.006939,0.004497,0.003447,0.006894,0.011756,0.003447,0.009108,0.009291,0.007875,0.009039,0.003447,0.010843,0.006209,0.003447,0.017280,0.011550,0.005219,0.007533]},{w:"tiple tumor locations per patient, all test results were considered. A predicted sensitive ",p:[0.117647,0.368218,0.857052,0.368218,0.857052,0.347845,0.117647,0.347845,0.006437,0.005273,0.011162,0.005182,0.009039,0.005650,0.006163,0.011413,0.017485,0.010843,0.007807,0.005650,0.005182,0.011276,0.009108,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.005650,0.011505,0.009039,0.007807,0.005650,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.004497,0.005650,0.009405,0.005387,0.005250,0.005650,0.006209,0.009039,0.007510,0.006437,0.005650,0.007442,0.009039,0.007510,0.011550,0.004908,0.006437,0.007670,0.005650,0.014518,0.009039,0.007442,0.009039,0.005650,0.008994,0.010843,0.011619,0.007601,0.005547,0.011322,0.009039,0.007442,0.009108,0.011117,0.004497,0.005650,0.014929,0.005650,0.011071,0.007442,0.009108,0.011391,0.005547,0.009108,0.006209,0.009108,0.011391,0.005650,0.007875,0.009039,0.011619,0.007601,0.005273,0.006437,0.005545,0.009635,0.009039,0.004109]},{w:"response (classified in the high-responsive subgroup) to at least one (and maximum five) ",p:[0.117647,0.388796,0.857077,0.388796,0.857077,0.368423,0.117647,0.368423,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.003629,0.006939,0.008765,0.005433,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.011391,0.003629,0.005615,0.011756,0.003629,0.006620,0.011299,0.009039,0.003629,0.011459,0.005615,0.009930,0.011459,0.007533,0.007439,0.009039,0.007512,0.011502,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.003629,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.006939,0.003629,0.006209,0.011048,0.003629,0.008811,0.006437,0.003629,0.005182,0.009291,0.009291,0.007510,0.006437,0.003629,0.010843,0.011596,0.009039,0.003629,0.006939,0.009085,0.011596,0.011391,0.003629,0.017577,0.009291,0.010089,0.005615,0.017280,0.011413,0.017645,0.003629,0.005684,0.005615,0.009635,0.009039,0.006939,0.004109]},{w:"drug(s) was observed for 88% of patients, except for HGS-1-R3, MC-3 and HG-26 in ",p:[0.117647,0.409375,0.857109,0.409375,0.857109,0.389002,0.117647,0.389002,0.011391,0.007967,0.011413,0.009861,0.006939,0.007670,0.006939,0.006015,0.014723,0.009291,0.007670,0.006026,0.010955,0.010934,0.007875,0.009039,0.008400,0.009633,0.009108,0.011391,0.006015,0.006026,0.010843,0.007807,0.006026,0.010432,0.010432,0.015043,0.006015,0.010843,0.006209,0.006026,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004497,0.006015,0.009108,0.009884,0.008994,0.009131,0.011048,0.006437,0.006015,0.006026,0.010845,0.007807,0.006015,0.016412,0.015682,0.010112,0.007533,0.010432,0.007533,0.013376,0.010432,0.004497,0.006026,0.019197,0.014678,0.007533,0.010432,0.006015,0.009085,0.011596,0.011391,0.006026,0.016412,0.015682,0.007533,0.010432,0.010432,0.006026,0.005615,0.011756,0.004109]},{w:"which all of the 13, seven and three tested monotherapies yielded a predicted resistant ",p:[0.117647,0.429954,0.857141,0.429954,0.857141,0.409581,0.117647,0.409581,0.014792,0.011459,0.005547,0.008765,0.011459,0.005524,0.009405,0.005385,0.005250,0.005524,0.010843,0.006209,0.005524,0.006620,0.011302,0.009039,0.005524,0.010432,0.010432,0.004497,0.005524,0.007875,0.009336,0.009633,0.009039,0.011756,0.005524,0.009085,0.011596,0.011391,0.005524,0.006620,0.011459,0.007442,0.009108,0.009039,0.005524,0.006209,0.009039,0.007510,0.006209,0.009108,0.011391,0.005524,0.017485,0.010843,0.011596,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011071,0.005547,0.009039,0.007670,0.005524,0.009724,0.005547,0.008948,0.005182,0.011322,0.009108,0.011391,0.005524,0.009291,0.005524,0.011071,0.007442,0.009108,0.011391,0.005545,0.009108,0.006209,0.009108,0.011391,0.005524,0.007442,0.009039,0.007601,0.005615,0.007510,0.006551,0.009085,0.011391,0.006437,0.004109]},{w:"response (classified in the low-responsive subgroup) in at least one of their PDOs (",p:[0.117647,0.450532,0.817471,0.450532,0.817471,0.430160,0.117647,0.430160,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004919,0.006939,0.008765,0.005433,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.011391,0.004919,0.005615,0.011756,0.004931,0.006617,0.011302,0.009039,0.004919,0.005182,0.010866,0.014723,0.007533,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.004919,0.007512,0.011345,0.011025,0.009861,0.007442,0.010820,0.011069,0.011276,0.006939,0.004931,0.005615,0.011756,0.004919,0.008811,0.006437,0.004931,0.005182,0.009291,0.009291,0.007510,0.006437,0.004919,0.010843,0.011596,0.009039,0.004931,0.010843,0.006209,0.004919,0.006620,0.011299,0.009039,0.005615,0.007807,0.004919,0.011664,0.016504,0.016253,0.007670,0.004931,0.006939]},{w:"Fig-",p:[0.817422,0.450532,0.852941,0.450532,0.852941,0.429400,0.817422,0.429400,0.011596,0.006209,0.010500,0.007213]},{w:"ure 3; Table S3",p:[0.117647,0.471111,0.245201,0.471111,0.245201,0.449978,0.117647,0.449978,0.011893,0.008263,0.009473,0.004018,0.010911,0.005433,0.004018,0.011413,0.009679,0.011528,0.005933,0.009473,0.004018,0.010592,0.010911]},{w:").",p:[0.245201,0.471111,0.256637,0.471111,0.256637,0.450738,0.245201,0.450738,0.006939,0.004497]},{w:"Figure 3: Overview of OC PDO response to single drugs per patient. ",p:[0.117647,0.838791,0.648744,0.838791,0.648744,0.821500,0.117647,0.821500,0.009488,0.005080,0.008797,0.009730,0.006761,0.007751,0.006574,0.008927,0.004445,0.006574,0.014101,0.007863,0.007583,0.007657,0.008404,0.005155,0.008255,0.011990,0.006574,0.009264,0.005678,0.006574,0.013875,0.012084,0.006574,0.010365,0.013727,0.013671,0.006574,0.006761,0.007751,0.006574,0.009880,0.009262,0.009786,0.006742,0.007751,0.006574,0.005622,0.009450,0.006574,0.006462,0.005080,0.009786,0.008778,0.004856,0.007751,0.006574,0.009712,0.007284,0.009730,0.008442,0.006574,0.006574,0.009880,0.007583,0.007022,0.006574,0.009786,0.007805,0.005752,0.005155,0.007583,0.009861,0.005939,0.004445,0.003287]},{w:"Overview of the number of ",p:[0.651981,0.838791,0.856321,0.838791,0.856321,0.822122,0.651981,0.822122,0.013821,0.007881,0.007396,0.006873,0.008050,0.004538,0.007639,0.012046,0.006724,0.008871,0.005080,0.006724,0.005416,0.009245,0.007396,0.006724,0.009320,0.009338,0.014231,0.009207,0.007396,0.006387,0.006724,0.008871,0.005080,0.003362]},{w:"monotherapies tested per patient (3-13), classified as low or high responsive, based on the IC50-value ",p:[0.117647,0.853343,0.856314,0.853343,0.856314,0.836674,0.117647,0.836674,0.014306,0.008871,0.009488,0.008853,0.005416,0.009245,0.007396,0.006462,0.007209,0.009058,0.004538,0.007396,0.006275,0.006387,0.005080,0.007396,0.006145,0.005080,0.007452,0.009320,0.006387,0.009413,0.007396,0.006387,0.006387,0.009301,0.007209,0.005267,0.004538,0.007396,0.009320,0.005267,0.006387,0.005678,0.008535,0.006163,0.008535,0.008535,0.005678,0.003679,0.006387,0.007172,0.004445,0.007601,0.006163,0.006219,0.004594,0.004650,0.004594,0.007452,0.009320,0.006387,0.007601,0.006275,0.006387,0.004240,0.008890,0.012046,0.006387,0.008869,0.006387,0.006387,0.009376,0.004594,0.008124,0.009376,0.006387,0.006089,0.007396,0.006145,0.009413,0.008871,0.009506,0.006219,0.004538,0.007881,0.007153,0.003679,0.006387,0.009095,0.007601,0.006443,0.007450,0.009320,0.006387,0.008871,0.009618,0.006387,0.005416,0.009245,0.007396,0.006387,0.005584,0.012009,0.008535,0.008535,0.006163,0.008050,0.007693,0.004015,0.009282,0.007396,0.003362]},{w:"relative to the ",p:[0.117647,0.867895,0.216223,0.867895,0.216223,0.851226,0.117647,0.851226,0.006089,0.007321,0.004445,0.007209,0.005267,0.004538,0.007881,0.007396,0.004445,0.005082,0.009039,0.004445,0.005416,0.009245,0.007396,0.003362]},{w:"in vivo",p:[0.217319,0.867895,0.262693,0.867895,0.262693,0.851054,0.217319,0.851054,0.004165,0.009245,0.004548,0.007601,0.004221,0.007471,0.008124]},{w:" plasma concentration (Css/Cmax, Table S3). For the majority of patients (88%) high ",p:[0.262694,0.867895,0.856247,0.867895,0.856247,0.851226,0.262694,0.851226,0.004445,0.009133,0.004443,0.007601,0.006219,0.014381,0.007601,0.004445,0.007359,0.008871,0.009488,0.007359,0.007396,0.009320,0.005267,0.006462,0.007209,0.005267,0.004538,0.008871,0.009618,0.004445,0.005678,0.012009,0.006161,0.006275,0.005808,0.011953,0.014381,0.007601,0.008255,0.003679,0.004445,0.008927,0.007452,0.008927,0.004240,0.007396,0.004445,0.008274,0.008535,0.005678,0.003679,0.004445,0.008741,0.008871,0.006387,0.004445,0.005416,0.009245,0.007396,0.004445,0.014381,0.007209,0.004370,0.008871,0.006387,0.004314,0.005267,0.007956,0.004445,0.008871,0.005080,0.004445,0.009301,0.007209,0.005267,0.004538,0.007396,0.009320,0.005267,0.006275,0.004445,0.005678,0.008535,0.008535,0.012308,0.005678,0.004445,0.009376,0.004594,0.008124,0.009376,0.003362]},{w:"responsiveness to at least one tested drug was identified. For patients with organoids derived from multiple ",p:[0.117647,0.882447,0.856305,0.882447,0.856305,0.865778,0.117647,0.865778,0.006089,0.007396,0.006145,0.009413,0.008871,0.009506,0.006219,0.004538,0.007881,0.007396,0.009488,0.007396,0.006163,0.006275,0.003745,0.005080,0.009039,0.003745,0.007209,0.005267,0.003745,0.004240,0.007601,0.007601,0.006145,0.005267,0.003745,0.008871,0.009488,0.007396,0.003745,0.005080,0.007396,0.006145,0.005080,0.007452,0.009320,0.003743,0.009320,0.006518,0.009338,0.008068,0.003745,0.012046,0.007601,0.006275,0.003745,0.004538,0.009264,0.007396,0.009320,0.005267,0.004594,0.004650,0.004593,0.007452,0.009095,0.003679,0.003745,0.008741,0.008871,0.006387,0.003745,0.009301,0.007209,0.005267,0.004538,0.007396,0.009320,0.005267,0.006275,0.003745,0.012046,0.004312,0.005416,0.009376,0.003745,0.008871,0.006238,0.008068,0.007433,0.009488,0.008873,0.004537,0.009320,0.006275,0.003745,0.009264,0.007396,0.006387,0.004538,0.007881,0.007452,0.009320,0.003745,0.005248,0.006089,0.008871,0.014437,0.003745,0.014138,0.009448,0.004017,0.005267,0.004314,0.009133,0.004240,0.007396,0.003362]},{w:"tumor locations, results from all tested samples were considered. Red=low responsive, blue=high responsive.",p:[0.117647,0.896999,0.852939,0.896999,0.852939,0.880331,0.117647,0.880331,0.005043,0.009338,0.014306,0.008871,0.006387,0.002857,0.004240,0.009226,0.007452,0.007209,0.005267,0.004538,0.008871,0.009506,0.006275,0.003679,0.002857,0.006089,0.007396,0.006145,0.009450,0.004015,0.005267,0.006275,0.002857,0.005248,0.006089,0.008871,0.014437,0.002857,0.007695,0.004408,0.004296,0.002857,0.005080,0.007396,0.006145,0.005080,0.007452,0.009320,0.002857,0.006499,0.007433,0.014138,0.009133,0.004240,0.007396,0.006275,0.002857,0.011878,0.007396,0.006089,0.007396,0.002857,0.007359,0.008871,0.009506,0.006219,0.004538,0.009264,0.007396,0.006089,0.007452,0.009095,0.003679,0.002857,0.011206,0.007452,0.009320,0.009637,0.004240,0.008890,0.012046,0.002857,0.006089,0.007396,0.006145,0.009413,0.008871,0.009506,0.006219,0.004538,0.007881,0.007153,0.003679,0.002857,0.008927,0.004015,0.009282,0.007396,0.009637,0.009376,0.004594,0.008124,0.009376,0.002857,0.006089,0.007396,0.006145,0.009413,0.008871,0.009506,0.006219,0.004538,0.007881,0.007153,0.003679]},{w:"Legend",p:[0.751486,0.641495,0.795836,0.641495,0.795836,0.629251,0.751486,0.629251,0.007620,0.006934,0.007620,0.006934,0.007620,0.007620]},{w:"Figure 3. Overview of OC PDO response to single drugs per patient",p:[0.163261,0.486563,0.588581,0.486563,0.588581,0.473094,0.163261,0.473094,0.008190,0.003622,0.008190,0.008190,0.005145,0.007436,0.003622,0.007436,0.003622,0.003622,0.010481,0.007436,0.007436,0.005145,0.007436,0.003622,0.007436,0.010481,0.003622,0.008190,0.004376,0.003622,0.010481,0.009713,0.003622,0.008958,0.009713,0.010481,0.003622,0.005145,0.007436,0.007436,0.008190,0.008190,0.008190,0.007436,0.007436,0.003622,0.004376,0.008190,0.003622,0.007436,0.003622,0.008190,0.008190,0.003622,0.007436,0.003622,0.008190,0.005145,0.008190,0.008190,0.007436,0.003622,0.008190,0.007436,0.005145,0.003622,0.008190,0.007436,0.004376,0.003622,0.007436,0.008190,0.004568]},{w:"Sample",p:[0.169970,0.662212,0.169970,0.630788,0.152684,0.630788,0.152684,0.662212,0.000000,0.000000,0.000000,0.000000,0.000000,0.044363]},{w:"Low-responsive",p:[0.770297,0.654368,0.831428,0.654368,0.831428,0.646138,0.770297,0.646138,0.004854,0.004854,0.006303,0.002907,0.002907,0.004854,0.004365,0.004854,0.004854,0.004854,0.004365,0.001938,0.004365,0.004854]},{w:"High-responsive",p:[0.770297,0.665630,0.833366,0.665630,0.833366,0.657399,0.770297,0.657399,0.006303,0.001938,0.004854,0.004854,0.002907,0.002907,0.004854,0.004365,0.004854,0.004854,0.004854,0.004365,0.001938,0.004365,0.004854]},{w:"100%",p:[0.311837,0.782946,0.334161,0.782946,0.334161,0.774715,0.311837,0.774715,0.004854,0.004854,0.004854,0.007761]},{w:"0%",p:[0.316617,0.771224,0.329233,0.771224,0.329233,0.762993,0.316617,0.762993,0.004854,0.007761]},{w:"17%",p:[0.433846,0.759499,0.451316,0.759499,0.451316,0.751268,0.433846,0.751268,0.004854,0.004854,0.007761]},{w:"57%",p:[0.473711,0.747776,0.491181,0.747776,0.491181,0.739546,0.473711,0.739546,0.004854,0.004854,0.007761]},{w:"43%",p:[0.473711,0.736058,0.491181,0.736058,0.491181,0.727827,0.473711,0.727827,0.004854,0.004854,0.007761]},{w:"29%",p:[0.473711,0.724335,0.491181,0.724335,0.491181,0.716104,0.473711,0.716104,0.004854,0.004854,0.007761]},{w:"29%",p:[0.473711,0.712612,0.491181,0.712612,0.491181,0.704381,0.473711,0.704381,0.004854,0.004854,0.007761]},{w:"14%",p:[0.473711,0.700888,0.491181,0.700888,0.491181,0.692657,0.473711,0.692657,0.004854,0.004854,0.007761]},{w:"14%",p:[0.473711,0.689170,0.491181,0.689170,0.491181,0.680939,0.473711,0.680939,0.004854,0.004854,0.007761]},{w:"0%",p:[0.476102,0.677447,0.488718,0.677447,0.488718,0.669216,0.476102,0.669216,0.004854,0.007761]},{w:"50%",p:[0.513585,0.665723,0.531055,0.665723,0.531055,0.657492,0.513585,0.657492,0.004854,0.004854,0.007761]},{w:"12%",p:[0.513585,0.654005,0.531055,0.654005,0.531055,0.645774,0.513585,0.645774,0.004854,0.004854,0.007761]},{w:"12%",p:[0.513585,0.642283,0.531055,0.642283,0.531055,0.634052,0.513585,0.634052,0.004854,0.004854,0.007761]},{w:"50%",p:[0.593332,0.630559,0.610802,0.630559,0.610802,0.622328,0.593332,0.622328,0.004854,0.004854,0.007761]},{w:"20%",p:[0.593332,0.618835,0.610802,0.618835,0.610802,0.610604,0.593332,0.610604,0.004854,0.004854,0.007761]},{w:"17%",p:[0.673078,0.607118,0.690548,0.607118,0.690548,0.598887,0.673078,0.598887,0.004854,0.004854,0.007761]},{w:"17%",p:[0.673078,0.595394,0.690548,0.595394,0.690548,0.587163,0.673078,0.587163,0.004854,0.004854,0.007761]},{w:"38%",p:[0.712943,0.583671,0.730413,0.583671,0.730413,0.575440,0.712943,0.575440,0.004854,0.004854,0.007761]},{w:"31%",p:[0.712943,0.571947,0.730413,0.571947,0.730413,0.563717,0.712943,0.563717,0.004854,0.004854,0.007761]},{w:"31%",p:[0.712943,0.560229,0.730413,0.560229,0.730413,0.551999,0.712943,0.551999,0.004854,0.004854,0.007761]},{w:"23%",p:[0.712943,0.548506,0.730413,0.548506,0.730413,0.540275,0.712943,0.540275,0.004854,0.004854,0.007761]},{w:"23%",p:[0.712943,0.536782,0.730413,0.536782,0.730413,0.528551,0.712943,0.528551,0.004854,0.004854,0.007761]},{w:"23%",p:[0.712943,0.525064,0.730413,0.525064,0.730413,0.516834,0.712943,0.516834,0.004854,0.004854,0.007761]},{w:"15%",p:[0.712943,0.513341,0.730413,0.513341,0.730413,0.505110,0.712943,0.505110,0.004854,0.004854,0.007761]},{w:"0%",p:[0.715333,0.501618,0.727949,0.501618,0.727949,0.493387,0.715333,0.493387,0.004854,0.007761]},{w:"HGS−10",p:[0.181985,0.782946,0.215710,0.782946,0.215710,0.774715,0.181985,0.774715,0.006303,0.006792,0.005823,0.005098,0.004854,0.004854]},{w:"HG−26",p:[0.187808,0.771221,0.215710,0.771221,0.215710,0.762990,0.187808,0.762990,0.006303,0.006792,0.005098,0.004854,0.004854]},{w:"LGS−5",p:[0.188288,0.759496,0.215710,0.759496,0.215710,0.751265,0.188288,0.751265,0.004854,0.006792,0.005823,0.005098,0.004854]},{w:"HG-25",p:[0.189999,0.747771,0.215710,0.747771,0.215710,0.739541,0.189999,0.739541,0.006303,0.006792,0.002907,0.004854,0.004854]},{w:"HGS−6",p:[0.186839,0.736053,0.215710,0.736053,0.215710,0.727822,0.186839,0.727822,0.006303,0.006792,0.005823,0.005098,0.004854]},{w:"MBT−1",p:[0.187328,0.724328,0.215710,0.724328,0.215710,0.716097,0.187328,0.716097,0.007272,0.005823,0.005334,0.005098,0.004854]},{w:"MC−2",p:[0.192182,0.712603,0.215710,0.712603,0.215710,0.704372,0.192182,0.704372,0.007272,0.006303,0.005098,0.004854]},{w:"HGS−24",p:[0.181985,0.700878,0.215710,0.700878,0.215710,0.692647,0.181985,0.692647,0.006303,0.006792,0.005823,0.005098,0.004854,0.004854]},{w:"MC−1",p:[0.192182,0.689159,0.215710,0.689159,0.215710,0.680928,0.192182,0.680928,0.007272,0.006303,0.005098,0.004854]},{w:"MC−3",p:[0.192182,0.677434,0.215710,0.677434,0.215710,0.669203,0.192182,0.669203,0.007272,0.006303,0.005098,0.004854]},{w:"HGS−2",p:[0.186839,0.665709,0.215710,0.665709,0.215710,0.657478,0.186839,0.657478,0.006303,0.006792,0.005823,0.005098,0.004854]},{w:"MBT−2",p:[0.187328,0.653990,0.215710,0.653990,0.215710,0.645759,0.187328,0.645759,0.007272,0.005823,0.005334,0.005098,0.004854]},{w:"SBT−3",p:[0.188777,0.642265,0.215710,0.642265,0.215710,0.634034,0.188777,0.634034,0.005823,0.005823,0.005334,0.005098,0.004854]},{w:"LGS−3",p:[0.188288,0.630540,0.215710,0.630540,0.215710,0.622310,0.188288,0.622310,0.004854,0.006792,0.005823,0.005098,0.004854]},{w:"LGS−2",p:[0.188288,0.618816,0.215710,0.618816,0.215710,0.610585,0.188288,0.610585,0.004854,0.006792,0.005823,0.005098,0.004854]},{w:"LGS−1",p:[0.188288,0.607097,0.215710,0.607097,0.215710,0.598866,0.188288,0.598866,0.004854,0.006792,0.005823,0.005098,0.004854]},{w:"CCC−1",p:[0.186839,0.595372,0.215702,0.595372,0.215702,0.587141,0.186839,0.587141,0.006303,0.006303,0.006303,0.005098,0.004854]},{w:"HGS−22",p:[0.181976,0.583647,0.215702,0.583647,0.215702,0.575416,0.181976,0.575416,0.006303,0.006792,0.005823,0.005098,0.004854,0.004854]},{w:"HGS−3",p:[0.186830,0.571922,0.215702,0.571922,0.215702,0.563691,0.186830,0.563691,0.006303,0.006792,0.005823,0.005098,0.004854]},{w:"HGS−23",p:[0.181976,0.560203,0.215702,0.560203,0.215702,0.551972,0.181976,0.551972,0.006303,0.006792,0.005823,0.005098,0.004854,0.004854]},{w:"HGS−13",p:[0.181976,0.548478,0.215702,0.548478,0.215702,0.540247,0.181976,0.540247,0.006303,0.006792,0.005823,0.005098,0.004854,0.004854]},{w:"END−1",p:[0.187319,0.536753,0.215702,0.536753,0.215702,0.528522,0.187319,0.528522,0.005823,0.006303,0.006303,0.005098,0.004854]},{w:"HGS−1",p:[0.186830,0.525034,0.215702,0.525034,0.215702,0.516803,0.186830,0.516803,0.006303,0.006792,0.005823,0.005098,0.004854]},{w:"HGS−1−R2",p:[0.170574,0.513309,0.215702,0.513309,0.215702,0.505079,0.170574,0.505079,0.006303,0.006792,0.005823,0.005098,0.004854,0.005098,0.006303,0.004854]},{w:"HGS−1−R3",p:[0.170574,0.501585,0.215702,0.501585,0.215702,0.493354,0.170574,0.493354,0.006303,0.006792,0.005823,0.005098,0.004854,0.005098,0.006303,0.004854]},{w:"0",p:[0.220758,0.794891,0.225612,0.794891,0.225612,0.786660,0.220758,0.786660,0.004854]},{w:"1",p:[0.260629,0.794891,0.265484,0.794891,0.265484,0.786660,0.260629,0.786660,0.004854]},{w:"2",p:[0.300501,0.794891,0.305355,0.794891,0.305355,0.786660,0.300501,0.786660,0.004854]},{w:"3",p:[0.340364,0.794891,0.345218,0.794891,0.345218,0.786660,0.340364,0.786660,0.004854]},{w:"4",p:[0.380236,0.794891,0.385090,0.794891,0.385090,0.786660,0.380236,0.786660,0.004854]},{w:"5",p:[0.420108,0.794891,0.424962,0.794891,0.424962,0.786660,0.420108,0.786660,0.004854]},{w:"6",p:[0.459980,0.794891,0.464834,0.794891,0.464834,0.786660,0.459980,0.786660,0.004854]},{w:"7",p:[0.499852,0.794891,0.504706,0.794891,0.504706,0.786660,0.499852,0.786660,0.004854]},{w:"8",p:[0.539715,0.794891,0.544569,0.794891,0.544569,0.786660,0.539715,0.786660,0.004854]},{w:"9",p:[0.579586,0.794891,0.584441,0.794891,0.584441,0.786660,0.579586,0.786660,0.004854]},{w:"10",p:[0.617066,0.794891,0.626774,0.794891,0.626774,0.786660,0.617066,0.786660,0.004854,0.004854]},{w:"11",p:[0.656938,0.794891,0.666646,0.794891,0.666646,0.786660,0.656938,0.786660,0.004854,0.004854]},{w:"12",p:[0.696810,0.794891,0.706518,0.794891,0.706518,0.786660,0.696810,0.786660,0.004854,0.004854]},{w:"13",p:[0.736682,0.794891,0.746390,0.794891,0.746390,0.786660,0.736682,0.786660,0.004854,0.004854]},{w:"Drugs tested",p:[0.447650,0.809035,0.523878,0.809035,0.523878,0.796791,0.447650,0.796791,0.009005,0.004852,0.007620,0.007620,0.006934,0.003467,0.004153,0.006934,0.006934,0.004153,0.006934,0.007620]}]};